Iran Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Iran Pharmaceuticals and Healthcare Report

Iran Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Iran Pharmaceuticals and Healthcare Report
Published Sep 24, 2016
99 pages — Published Sep 24, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

Low taxes on foreign-made drugs that are not manufactured locally. Expanding public health insurance coverage boosting demand for generic medicines. ...Expanding public health insurance coverage boosting demand for generic medicines. Improved international relations may increase confidence of multinational drugmakers to invest in the market. Increased investment in local pharmaceutical capacities. ...Construction of private pharmaceutical city to house --- companies.

...In August ----, Vice President for Science and Technology Sorena Sattari announced plans for Iran to commence the exporting of pharmaceuticals to Europe. The plan comes both as a result of Iran s ability of satisfying almost all internal demand with domestic production (-- ) and greater opportunities for trade post-sanctions. ...The plan comes both as a result of Iran s ability of satisfying almost all internal demand with domestic production (-- ) and greater opportunities for trade post-sanctions. � In August ----, Iranian and Swedish government representatives met to discuss expanding economic cooperation, particularly in the areas of pharmaceutical industries and medical equipment and infrastructure. As part of the negotiations, officials from both sides agreed to examine the feasibility of a joint construction hospital project in Tehran. ...� In August ----, Iranian and Swedish government representatives met to discuss expanding economic cooperation, particularly in the areas of pharmaceutical industries and medical equipment and infrastructure. As part of the negotiations, officials from both sides agreed to examine the feasibility of a joint construction hospital project in Tehran.

...Iran scores --.- out of --- in terms of its attractiveness as a destination to launch innovative pharmaceuticals in Q---, maintaining its score from the previous quarter, according to BMI s Risk/Reward Index. Iran s position in the index remains stationary at --th out of -- countries in the Middle East and Africa region. Its overall score currently sits exactly at the regional average of --.-. Generally speaking, Iran benefits from a large and growing population and relatively widespread access to healthcare services. However, its regulatory regime - including intellectual property rights and economic ...

  
Source:
Document ID
1748-1953
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Iran Pharmaceuticals and Healthcare Report" Sep 24, 2016. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Iran-Pharmaceuticals-and-Healthcare-Report-2026-535>
  
APA:
Business Monitor International - Industry Reports. (2016). Iran Pharmaceuticals and Healthcare Report Sep 24, 2016. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Iran-Pharmaceuticals-and-Healthcare-Report-2026-535>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.